The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment
Invest New Drugs
August 2013
https://pubmed.ncbi.nlm.nih.gov/23275062/
Metabolic treatment of cancer: intermediate results of a prospective case series
Anticancer Res
February 2014
https://pubmed.ncbi.nlm.nih.gov/24511042/
Background: The combination of hydroxycitrate and lipoic acid has been demonstrated by several laboratories to be effective in reducing murine cancer growth.
Long-term remission of adenoid cystic tongue carcinoma with low dose naltrexone and vitamin D3--a case report
Oral Health Dent Manag
September 2014
http://oralhealth.ro/volumes/2014/volume-3/Paper662.pdf
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases
Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/
Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone
Cancer Lett
29 March 1996
https://pubmed.ncbi.nlm.nih.gov/8620464/
Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors
Brain Res
20 February 1989
https://pubmed.ncbi.nlm.nih.gov/2540873/
Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems
Life Sci
21 September 1987
https://pubmed.ncbi.nlm.nih.gov/3041143/
Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer
Life Sci
23 July 1984
https://pubmed.ncbi.nlm.nih.gov/6087062/
Naltrexone modulates tumor response in mice with neuroblastoma
Science
12 August 1983
https://pubmed.ncbi.nlm.nih.gov/6867737/
Opioid antagonists inhibit the growth of metastatic murine neuroblastoma
Cancer Lett
November 1983
https://pubmed.ncbi.nlm.nih.gov/6640516/